FOLD Q2 2021 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+24.2% YoY

Gross Profit

$69M89.2% margin

Operating Income

-$39M-50.2% margin

Net Income

-$51M-66.2% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+16.6%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$787M

Total Liabilities

$573M

Stockholders' Equity

$214M

Cash & Equivalents

$177M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$62M	+24.2%
Gross Profit	$69M	$56M	+24.0%
Operating Income	-$39M	-$51M	+24.4%
Net Income	-$51M	-$52M	+2.4%

Geographic Segments

Non-US

$54M69%

UNITED STATES

$24M31%